| 查看: 3181 | 回复: 30 | ||
| 【奖励】 本帖被评价15次，作者whl0903增加金币 8.75 个 | ||
| 当前主题已经存档。 | ||
[资源]
绿宝书的电子版
|
||
|
电子版用起来特别方便！ [ Last edited by whl0903 on 2008-9-2 at 05:06 ] |
回复此楼» 猜你喜欢
研究生做的很差，你们会让毕业吗？
已经有11人回复
-
申博自荐
已经有8人回复
-
26年博士申请自荐-电催化
已经有8人回复
-
求碳排放博导；方向是LCA、生命周期可持续发展以及碳排放
已经有7人回复
-
2026博士申请求助
已经有4人回复
-
2026博士或科研助理转27年博士
已经有7人回复
-
急招2026年9月份入学博士
已经有3人回复
-
2026年博士申请求捞
已经有3人回复
-
国自科送审了吗
已经有11人回复
-
博士招生
已经有5人回复
2楼2008-09-02 07:33:48
5楼2008-09-02 17:34:40
6楼2008-09-03 07:35:42
7楼2008-09-03 11:05:34
8楼2008-09-03 15:30:49
10楼2008-09-03 19:41:26
11楼2008-09-03 21:08:58
13楼2008-11-02 21:03:08
14楼2008-11-04 09:49:18
15楼2008-11-08 15:52:33
16楼2008-11-08 19:32:39
|
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). A total of 48,440 Enterobacteriaceae isolates collected consecutively from patients hospitalized in participant SENTRY Antimicrobial Surveillance Program sites in four international regions (Asia-Pacific, Europe, Latin America, and North America) were tested by reference broth microdilution method against the most commonly used antimicrobial agents. The most active compounds could be divided in 3 groups based on their spectrum of activity. The first group included meropenem and imipenem, with 99.9% susceptibilty (S) rates for the Enterobacteriaceae. The second group includes amikacin (97.3% S) and cefepime (97.2% S); and a third active group had a rank order of susceptibility of: gatifloxacin = levofloxacin (91.7% S) > ceftazidime (91.4% S) > ceftriaxone (91.2% S) > aztreonam (91.1% S) > gentamicin (90.6% S) > piperacillin/tazobactam = ciprofloxacin (90.5% susceptibility). These latter antimicrobial agents presented susceptibility rates of approximately 90% (89.8%-91.7%). Continued resistance surveillance by various programs remain necessary to monitor the in vitro effectiveness of antimicrobial agents currently used in clinical practice.（9） |
17楼2008-11-09 20:47:39
|
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). A total of 48,440 Enterobacteriaceae isolates collected consecutively from patients hospitalized in participant SENTRY Antimicrobial Surveillance Program sites in four international regions (Asia-Pacific, Europe, Latin America, and North America) were tested by reference broth microdilution method against the most commonly used antimicrobial agents. The most active compounds could be divided in 3 groups based on their spectrum of activity. The first group included meropenem and imipenem, with 99.9% susceptibilty (S) rates for the Enterobacteriaceae. The second group includes amikacin (97.3% S) and cefepime (97.2% S); and a third active group had a rank order of susceptibility of: gatifloxacin = levofloxacin (91.7% S) > ceftazidime (91.4% S) > ceftriaxone (91.2% S) > aztreonam (91.1% S) > gentamicin (90.6% S) > piperacillin/tazobactam = ciprofloxacin (90.5% susceptibility). These latter antimicrobial agents presented susceptibility rates of approximately 90% (89.8%-91.7%). Continued resistance surveillance by various programs remain necessary to monitor the in vitro effectiveness of antimicrobial agents currently used in clinical practice.（9） |
18楼2008-11-09 20:47:54
19楼2008-11-09 22:09:47
21楼2009-03-05 09:52:05
22楼2009-05-24 03:25:27
23楼2009-05-31 01:34:57
24楼2009-07-10 19:22:14
简单回复
wing13443楼
2008-09-02 10:41
回复
谢谢分享！
2008-09-02 12:13
回复
2008-09-03 19:26
回复
glynwell12楼
2008-09-04 01:30
回复
csz0742400320楼
2008-11-10 07:07
回复
谢谢分享！